Economic Liberties Applauds New Pennsylvania Antitrust Reform Bill
June 24, 2022 — The American Economic Liberties Project released a statement following the introduction of The Open Markets Act in Pennsylvania.
Economic Liberties Breaks Down the Pharmacy Benefit Mafia
June 22, 2022 — Washington D.C. — On the heels of the Federal Trade Commission’s recently announced 6(b) study of pharmacy benefit mangers (PBMs), the American Economic Liberties Project today released a critical new explainer: The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists.
Big Tech Monopolies Endanger American Security
June 17, 2022 — As lawmakers in Washington accelerate efforts to crack down on Big Tech, the monopolies have doubled down on a lobbying campaign that claims their concentrated power is essential for America’s national security interests and competition with China. Today, the American Economic Liberties Project released a report entitled, “Big Tech Monopolies Endanger American Security,” which presents irrefutable evidence that this argument is hollow from the inside out.
FTC Vote to Resurrect Robinson-Patman Will Help Lower Cost of Drugs & Insulin
June 16, 2022 — The American Economic Liberties Project released a statement in response to a unanimous vote from the Federal Trade Commission on a policy statement to resurrect the use of an old law against corporate bribery, and to use this law to take on the insulin cartel.
Economic Liberties Pushes Surface Transportation Board to Block Railroad Merger Between Canadian Pacific and Kansas City Southern
June 10, 2022 — The American Economic Liberties Project submitted a letter to the Surface Transportation Board regarding the proposed merger between two Class I railroads, Canadian Pacific and Kansas City Southern.